What happened to the variants that once wreaked havoc? “For all intents and purposes, we can consider them gone,” said David Dowdy, an epidemiology professor at Johns Hopkins Bloomberg School of Public Health.
Analysis of a subgroup of patients hospitalized primarily for COVID-19 or flu found that the risk of death was 2.5 times higher, and the likelihood of ICU admission was 1.7 times higher, among Omicron than flu patients.
Long-COVID patients have higher rates of unemployment and underemployment than their recovered peers and are likely to have persistent or new-onset symptoms, disabilities, and financial problems in the 6 months after hospitalization, according to two US studies published in JAMA Network Open. ...
Federal health agencies worked to get more nursing home residents and staff to take the latest Covid booster all winter, creating social media hashtags, putting money into vaccine hotlines and flagging the worst performing facilities to states.
But their decision to scale back on two vaccine interventions that were critical in getting residents and staff protected from Covid during the first vaccine rollout in late 2020 and 2021 has left the job mostly to facilities, resident advocates say, with disappointing results.
Two new studies, one from the United States and one from Canada, suggest that the oral antiviral drug Paxlovid (nirmatrelvir-ritonavir) is effective in lowering the odds of hospitalization or death from the SARS-CoV-2 Omicron subvariant.
Recent Comments